Barclays »

Augmedix shares owned by Barclays

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $110k 19k 5.83
2023-09-30 $115k 22k 5.15

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Augmedix

Redmile Group
Samjo Management
Divisadero Street Capital Management
Perkins Capital Management
Vanguard Group
Caption Management
Russell Investments
G2 Investment Partners Management
American Financial Group
Balyasny Asset Management
Essex Investment Management
Kennedy Capital Management
Millennium Management
Point72 Asset Management
Resolute Capital Asset Partners

View all funds holding Augmedix